loader
Please Wait
Applying Filters...
menu
    • menu

    Annual Sales of 2-[(1,3-dicyclohexyl-2,4,6-trioxo-1,3-diazinane-5-carbonyl)amino]acetic acid reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    2-[(1,3-dicyclohexyl-2,4,6-trioxo-1,3-diazinane-5-carbonyl)amino]acetic acid

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 39,268Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 4Duvroq

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Duvroq

    Daprodustat

    arrow
    FNCE 2024
    Not Confirmed

    Brand Name : Duvroq

    Japan
    arrow
    FNCE 2024
    Not Confirmed

    Kyowa Kirin

    Daprodustat

    Main Therapeutic Indication : Hematology

    Currency : USD

    2020 Revenue in Millions : 6

    2019 Revenue in Millions : 0

    Growth (%) : New Launch

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Duvroq

    Daprodustat

    arrow
    FNCE 2024
    Not Confirmed

    Brand Name : Duvroq

    Japan
    arrow
    FNCE 2024
    Not Confirmed

    Kyowa Kirin

    Daprodustat

    Main Therapeutic Indication : Hematology

    Currency : USD

    2021 Revenue in Millions : 22

    2020 Revenue in Millions : 6

    Growth (%) : 333

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Duvroq

    Daprodustat

    arrow
    FNCE 2024
    Not Confirmed

    Brand Name : Duvroq

    Japan
    arrow
    FNCE 2024
    Not Confirmed

    Kyowa Kirin

    Daprodustat

    Main Therapeutic Indication : Hematology

    Currency : USD

    2022 Revenue in Millions : 50

    2021 Revenue in Millions : 22

    Growth (%) : 127

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Duvroq

    Daprodustat

    arrow
    FNCE 2024
    Not Confirmed

    Brand Name : Duvroq

    Japan
    arrow
    FNCE 2024
    Not Confirmed

    Kyowa Kirin

    Daprodustat

    Main Therapeutic Indication : Hematology

    Currency : USD

    2023 Revenue in Millions : 67

    2022 Revenue in Millions : 50

    Growth (%) : 50

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF